Literature DB >> 15652501

Expression of lysyl oxidase isoforms in MC3T3-E1 osteoblastic cells.

Phimon Atsawasuwan1, Yoshiyuki Mochida, Duenpim Parisuthiman, Mitsuo Yamauchi.   

Abstract

Covalent intermolecular cross-linking of collagen is initiated by the action of lysyl oxidase (LOX) on the telopeptidyl lysine and hydroxylysine residues. Recently, several LOX isoforms, i.e., LOX-like proteins 1-4 (LOXL1-4), have been identified but their specific tissue distribution and functions are still largely unknown. In this study, mRNA expression of LOX and LOXL1-4 in MC3T3-E1 osteoblastic cells was screened by RT-PCR and quantitatively analyzed by real-time PCR during cell differentiation and matrix mineralization. The results demonstrated that LOX and all LOXLs, except LOXL2, were expressed in this cell line and that the expression pattern during cell differentiation and matrix mineralization was distinct from one another. This indicates that the expression of LOX and its isoforms is highly regulated during osteoblast differentiation, suggesting their distinct roles in collagen matrix stabilization and subsequent mineralization.

Entities:  

Keywords:  NASA Discipline Cell Biology; Non-NASA Center

Mesh:

Substances:

Year:  2005        PMID: 15652501     DOI: 10.1016/j.bbrc.2004.12.119

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  The role of collagen in bone strength.

Authors:  S Viguet-Carrin; P Garnero; P D Delmas
Journal:  Osteoporos Int       Date:  2005-12-09       Impact factor: 4.507

2.  Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase.

Authors:  Alexia Eliades; Nikolaos Papadantonakis; Ajoy Bhupatiraju; Kelley A Burridge; Hillary A Johnston-Cox; Anna Rita Migliaccio; John D Crispino; Hector A Lucero; Philip C Trackman; Katya Ravid
Journal:  J Biol Chem       Date:  2011-06-10       Impact factor: 5.157

3.  Exogenous Lysyl Oxidase-Like 2 and Perfusion Culture Induce Collagen Crosslink Formation in Osteogenic Grafts.

Authors:  Debika Mitra; Osamu W Yasui; Jenna N Harvestine; Jarrett M Link; Jerry C Hu; Kyriacos A Athanasiou; J Kent Leach
Journal:  Biotechnol J       Date:  2018-08-16       Impact factor: 4.677

Review 4.  Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus.

Authors:  M Saito; K Marumo
Journal:  Osteoporos Int       Date:  2010-02       Impact factor: 4.507

5.  The role of lysyl oxidase-like 2 in the odontogenic differentiation of human dental pulp stem cells.

Authors:  Joo-Hyun Kim; Eun-Hyang Lee; Hye-Jeong Park; Eui-Kyun Park; Tae-Geon Kwon; Hong-In Shin; Je-Yoel Cho
Journal:  Mol Cells       Date:  2013-05-14       Impact factor: 5.034

6.  Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype.

Authors:  N Pischon; J M Mäki; P Weisshaupt; N Heng; A H Palamakumbura; P N'Guessan; A Ding; R Radlanski; H Renz; T A L J J Bronckers; J Myllyharju; A M Kielbassa; B M Kleber; J-P Bernimoulin; P C Trackman
Journal:  Calcif Tissue Int       Date:  2009-05-21       Impact factor: 4.333

7.  Post-translational modifications of collagen upon BMP-induced osteoblast differentiation.

Authors:  Masaru Kaku; Yoshiyuki Mochida; Phimon Atsawasuwan; Duenpim Parisuthiman; Mitsuo Yamauchi
Journal:  Biochem Biophys Res Commun       Date:  2007-05-25       Impact factor: 3.575

8.  Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture.

Authors:  M Saito; K Fujii; S Soshi; T Tanaka
Journal:  Osteoporos Int       Date:  2006-03-22       Impact factor: 4.507

Review 9.  Diabetes, collagen, and bone quality.

Authors:  Mitsuru Saito; Yoshikuni Kida; Soki Kato; Keishi Marumo
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

Review 10.  Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.

Authors:  Philip C Trackman
Journal:  Expert Opin Ther Targets       Date:  2016-03-03       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.